Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker-Reference-Cited by-同舟云学术

Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker

Published:2019-02-25 Issue:5 Volume:247 Page:641-649
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Lam Wai Kei Jacky¹²³^ORCID,Chan Kwan Chee Allen¹²³,Lo Yuk Ming Dennis¹²³

Affiliation:

1. Department of Chemical Pathology, The Chinese University of Hong KongPrince of Wales Hospital Shatin New Territories, Hong Kong SAR

2. Li Ka Shing Institute of Health SciencesThe Chinese University of Hong Kong Shatin New Territories, Hong Kong SAR

3. State Key Laboratory of Translational Oncology, Sir Y.K. Pao Centre for CancerThe Chinese University of Hong Kong, Shatin New Territories Hong Kong SAR

Funder

Chinese University of Hong Kong

Li Ka Shing Foundation

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5249

Reference76 articles.

1. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

2. Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

3. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

4. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

5. Cell-free nucleic acids as biomarkers in cancer patients

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of circular RNAs in nasopharyngeal carcinoma: functions and implications;Cell Death Discovery;2024-04-25

2. Revisiting TNM staging for EBV-related nasopharyngeal carcinoma;Cancer Cell;2024-03

3. Global, regional, and national survey on burden and quality of care index (QCI) of nasopharyngeal cancer: A systematic analysis of the Global Burden of disease study 1990–2019;Oral Oncology Reports;2024-03

4. Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application;Molecular Cancer;2024-02-17

5. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma;Oral Oncology;2024-01